Fetal growth restriction and a single umbilical artery are independent predictors of hypospadias during pregnancy.


Journal

Placenta
ISSN: 1532-3102
Titre abrégé: Placenta
Pays: Netherlands
ID NLM: 8006349

Informations de publication

Date de publication:
12 2022
Historique:
received: 07 06 2022
revised: 14 09 2022
accepted: 02 11 2022
pubmed: 20 11 2022
medline: 7 12 2022
entrez: 19 11 2022
Statut: ppublish

Résumé

Little is known about the association between hypospadias and small fetuses, as well as the pathological implications of fetal growth restriction (FGR). Thus, we aimed to investigate the association between hypospadias and small fetuses using a database of fetal ultrasound and obstetric events. A cohort of male singleton infants delivered after 22 weeks of gestation at Keio University Hospital between 2013 and 2019 was retrospectively reviewed. FGR was defined according to the Delphi criteria. Logistic regression analysis was performed to identify the significant predictors of hypospadias. Placental pathology was reviewed in cases with hypospadias. Of the 2,040 male infants included in the present study, 23 had hypospadias. The prevalences of a single umbilical artery (SUA), small for gestational age, maternal hypertensive disorders of pregnancy, and a small placenta, were significantly higher in infants with hypospadias. Multiple logistic regression analysis revealed that FGR (odds ratio [OR] = 9.39; 95% confidence interval [CI], 2.50-35.3) and the presence of a SUA (OR = 33.4; 95% CI, 8.00-139.5) were independently and significantly associated with hypospadias. When FGR was stratified by the time of onset, its association with hypospadias was significant regardless of the time of onset. Moreover, placental histological findings suggested that fetal vascular malperfusion might play a role in hypospadias. FGR and SUAs are independent prenatal predictors of the development of hypospadias, and fetal vascular malperfusion of the placenta may be involved in the etiology of hypospadias.

Identifiants

pubmed: 36401899
pii: S0143-4004(22)00451-9
doi: 10.1016/j.placenta.2022.11.001
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

53-59

Informations de copyright

Copyright © 2022 Elsevier Ltd. All rights reserved.

Déclaration de conflit d'intérêts

Declarations of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Toyohide Endo (T)

Department of Obstetrics and Gynecology, Keio University School of Medicine, Tokyo, Japan.

Miho Iida (M)

Department of Preventive Medicine and Public Health, Keio University School of Medicine, Tokyo, Japan.

Yosuke Ichihashi (Y)

Department of Pediatrics, Keio University School of Medicine, Tokyo, Japan.

Maki Oishi (M)

Department of Obstetrics and Gynecology, Keio University School of Medicine, Tokyo, Japan.

Satoru Ikenoue (S)

Department of Obstetrics and Gynecology, Keio University School of Medicine, Tokyo, Japan.

Yoshifumi Kasuga (Y)

Department of Obstetrics and Gynecology, Keio University School of Medicine, Tokyo, Japan.

Takeshi Sato (T)

Department of Pediatrics, Keio University School of Medicine, Tokyo, Japan.

Mariko Hida (M)

Department of Pediatrics, Keio University School of Medicine, Tokyo, Japan.

Tomohiro Ishii (T)

Department of Pediatrics, Keio University School of Medicine, Tokyo, Japan.

Hiroshi Asanuma (H)

Department of Urology, Keio University School of Medicine, Tokyo, Japan.

Tomonobu Hasegawa (T)

Department of Pediatrics, Keio University School of Medicine, Tokyo, Japan.

Mamoru Tanaka (M)

Department of Obstetrics and Gynecology, Keio University School of Medicine, Tokyo, Japan.

Daigo Ochiai (D)

Department of Obstetrics and Gynecology, Keio University School of Medicine, Tokyo, Japan; Department of Obstetrics and Gynecology, Kitasato University School of Medicine, Kanagawa, Japan. Electronic address: ochiaidaigo@keio.jp.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH